staurosporine has been researched along with Multiple Sclerosis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agnew, WS; Bendahhou, S; Cummins, TR; Potts, JF; Tong, J | 1 |
Grimaldi, LM; Martino, G | 1 |
Craighead, MW; Keynes, RG; Tiwari, P; Waters, CM | 1 |
Jurewicz, AM; Selmaj, KW; Walczak, AK | 1 |
Benjamins, JA; Studzinski, DM | 1 |
5 other study(ies) available for staurosporine and Multiple Sclerosis
Article | Year |
---|---|
Serine-1321-independent regulation of the mu 1 adult skeletal muscle Na+ channel by protein kinase C.
Topics: Adult; Alkaloids; Amino Acid Sequence; Base Sequence; Cell Line; Consensus Sequence; Conserved Sequence; DNA Primers; Enzyme Inhibitors; Ethers, Cyclic; Humans; Ion Channel Gating; Macromolecular Substances; Membrane Potentials; Molecular Sequence Data; Multiple Sclerosis; Muscle, Skeletal; Mutagenesis, Site-Directed; Naphthalenes; Okadaic Acid; Phosphorylation; Polymerase Chain Reaction; Polyradiculoneuropathy; Protein Kinase C; Recombinant Proteins; Serine; Sodium Channels; Staurosporine; Transfection | 1995 |
Effect of interferon gamma on T lymphocytes from patients with multiple sclerosis.
Topics: Antineoplastic Agents; Calcium; Carcinogens; Cells, Cultured; Chlorides; Enzyme Inhibitors; Female; Homeostasis; Humans; Imidazoles; Interferon-gamma; Lymphocyte Activation; Male; Multiple Sclerosis; Sodium; Staurosporine; T-Lymphocytes; Tetradecanoylphorbol Acetate | 1995 |
Human oligodendroglial cell line, MO3.13, can be protected from apoptosis using the general caspase inhibitor zVAD-FMK.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Caspase Inhibitors; Caspases; Cell Differentiation; Cell Line; Coumarins; Cysteine Proteinase Inhibitors; Enzyme Activation; Enzyme Inhibitors; Fluorescent Dyes; Humans; In Situ Nick-End Labeling; Multiple Sclerosis; Oligodendroglia; Oligopeptides; Staurosporine; Substrate Specificity | 1999 |
Shedding of TNF receptors in multiple sclerosis patients.
Topics: Antigens, CD; Cells, Cultured; Enzyme Inhibitors; Humans; Kinetics; Lymphocytes; Monocytes; Multiple Sclerosis; Protein Kinase C; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Solubility; Staurosporine; Tumor Necrosis Factor-alpha | 1999 |
Cyclic AMP differentiation of the oligodendroglial cell line N20.1 switches staurosporine-induced cell death from necrosis to apoptosis.
Topics: Animals; Apoptosis; Caspase Inhibitors; Caspases; Cell Differentiation; Cell Line, Transformed; Cell Nucleus; Central Nervous System; Coloring Agents; Cyclic AMP; DNA Fragmentation; DNA, Single-Stranded; Enzyme Inhibitors; Humans; Multiple Sclerosis; Necrosis; Oligodendroglia; Propidium; Staurosporine; Temperature; Trypan Blue | 2001 |